Stephanie Watts , PhD FAHA
Education
PhD, Pharmacology and Toxicology, Indiana University Indianapolis,
BS, Chemistry, The University of Illinois,
Postdoctoral Fellow, Physiology, The University of Michigan,
Employment
Professor, Michigan State University, East Lansing, 1995 - Present
Publications
5-Hydroxytryptamine may be a viable treatment option for hypertension resistant to diuretic treatment American Journal of Physiology-Heart and Circulatory Physiology (2025)
PVAT adipocyte: energizing, modulating, and structuring vascular function during normotensive and hypertensive states American Journal of Physiology-Heart and Circulatory Physiology (2025)
Perivascular Adipocytes’ Adipogenesis Is Defined by Their Anatomical Location in the Descending Thoracic Aorta Cells (2025)
Mechanotransduction in the Perivascular Adipose Tissue Arteriosclerosis, Thrombosis, and Vascular Biology (2025)
Vascular chemerin from PVAT contributes to norepinephrine and serotonin-induced vasoconstriction and vascular stiffness in a sex-dependent manner American Journal of Physiology-Heart and Circulatory Physiology (2024)
Innervation of adipocytes is limited in mouse perivascular adipose tissue American Journal of Physiology-Heart and Circulatory Physiology (2024)
A cell atlas of thoracic aortic perivascular adipose tissue: a focus on mechanotransducers American Journal of Physiology-Heart and Circulatory Physiology (2024)
How New Developments in Pharmacology Receptor Theory Are Changing (Our Understanding of) Hypertension Therapy American Journal of Hypertension (2024)
Development of a 5-HT7 receptor antibody for the rat: the good, the bad, and the ugly Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
Skin Vascular Resistance Decreases during 5-HT-Induced Hypotension in the Rat Biomedicines (2023)